Tero Aittokallio

Functional drug sensitivity and resistance profiling of AML patient cells defines a disease-specific combination of druggable signal addictions (2013)

Cancer Research

Pemovska T, Yadav B, Karjalainen R, Kulesskiy E, Kontro M, Majumder MM, Turunen L, Lindenschmidt I, Lehto A, Knowles J, Heckman C, Porkka K, Aittokallio T, Kallioniemi O, Wennerberg K

(Muu (O2))

Genetic variants and their interactions in disease risk prediction - machine learning and network perspectives (2013)

BioData Mining

Okser S, Pahikkala T, Aittokallio T

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling (2013)

Blood

Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A, Almusa H, Bespalov M, Ellonen P, Elonen E, Gjertsen BT, Karjalainen R, Kulesskiy E, Lagstrom S, Lehto A, Lepisto M, Lundan T, Majumder MM, Marti JML, Mattila P, Murumagi A, Mustjoki S, Palva A, Parsons A, Pirttinen T, Ramet ME, Suvela M, Turunen L, Vastrik I, Wolf M, Knowles J, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K

(Muu (O2))

Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screening (2013)

Clinical Cancer Research

Roering P, Mikkonen P, Kaipio K, Huhtinen K, Hynninen J, Auranen A, Kulesskiy E, Yadav B, Aittokallio T, Grenman S, Wennerberg K, Carpen O

(Muu (O2))

Stromal Cell Supported High-Throughput Drug Testing Of Primary Leukemia Cells For Comprehensive Assessment Of Sensitivity To Novel Therapies (2013)

Blood

Karjalainen R, Pemovska T, Yadav B, Majumder MM, Kontro M, Porkka K, Kallioniemi O, Aittokallio T, Wennerberg K, Heckman CA

(Muu (O2))

Identifying prognostically relevant subsets of endometrial cancer using unsupervised clustering of immunohistochemical staining data (2013)

Virchows Archiv

Huvila J, Laajala D, Edqvist PH, Talve L, Grenman S, Ponten F, Aittokallio T, Carpen O, Auranen A

(Muu (O2))

Parallel Feature Selection for Regularized Least-Squares (2013)

Lecture Notes in Computer Science

Sebastian Okser, Antti Airola, Tero Aittokallio, Tapio Salakoski, Tapio Pahikkala

(Vertaisarvioitu artikkeli konferenssijulkaisussa (A4))

Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo (2012)

Clinical Cancer Research

Laajala TD, Corander J, Saarinen NM, Makela K, Savolainen S, Suominen MI, Alhoniemi E, Makela S, Poutanen M, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Optimizing Detection of Transcription Factor-Binding Sites in ChIP-seq Experiments (2012)

Nucleic Acids Research

Elo LL, Kallio A, Laajala TD, Hawkins RD, Korpelainen E, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Identification of Personalized Therapeutic Strategies and Associated Biomarkers in Adult Acute Myeloid Leukemia Using a Functional Drug Sensitivity and Resistance Testing Platform (2012)

European Journal of Cancer

Pemovska T, Yadav B, Kulesskiy E, Kontro M, Heckman C, Knowles J, Porkka K, Aittokallio T, Kallioniemi O, Wennerberg K

(Muu (O2))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Functional drug sensitivity and resistance profiling of AML patient cells defines a disease-specific combination of druggable signal addictions (2013)

Genetic variants and their interactions in disease risk prediction - machine learning and network perspectives (2013)

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling (2013)

Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screening (2013)

Stromal Cell Supported High-Throughput Drug Testing Of Primary Leukemia Cells For Comprehensive Assessment Of Sensitivity To Novel Therapies (2013)

Identifying prognostically relevant subsets of endometrial cancer using unsupervised clustering of immunohistochemical staining data (2013)

Parallel Feature Selection for Regularized Least-Squares (2013)

Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo (2012)

Optimizing Detection of Transcription Factor-Binding Sites in ChIP-seq Experiments (2012)

Identification of Personalized Therapeutic Strategies and Associated Biomarkers in Adult Acute Myeloid Leukemia Using a Functional Drug Sensitivity and Resistance Testing Platform (2012)